Protective microglia subtype offers potential therapeutic pathway in Alzheimer's disease

In Alzheimer's disease—the leading cause of dementia—microglia, the brain's immune defenders, can act as both protectors and ...

Blood Tests for Alzheimer’s Are Here

New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive treatments—such as monoclonal antibodies—sooner.

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

This strategic filing with the FDA follows encouraging internal data and recent published studies supporting Nexalin’s ...

Shared synaptic mechanism for Alzheimer's and Parkinson's disease unlocks new treatment possibilities

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people ...
Bonner County Daily Bee

Encouraging news about the fight against Alzheimer’s

Bill Gates shares personal insights on Alzheimer’s and a new FDA-approved blood test that could revolutionize early diagnosis ...
My Edmonds News

Sponsor spotlight: 5 meaningful ways to support memory and to connect during Alzheimer’s Disease Awareness Month

Each November, Alzheimer’s Disease Awareness Month invites us to learn, reflect, and show support for the individuals and ...
University of California, Davis

CHANCELL-ING: Finding a Cure for Alzheimer’s Disease While Forming Friendships

The impact of Alzheimer’s Disease touches nearly all of us in some way. According to the Alzheimer’s Association, 1 in 9 ...

'Young' Immune Cells Partly Reverse Alzheimer's Symptoms in Mice

Specially engineered 'young' immune cells could help to reverse the effects of aging and the damage to brain cells caused by ...